Portolan Capital Management’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.5M Buy
177,432
+94,176
+113% +$6.66M 0.84% 39
2026
Q1
$3.28M Sell
83,256
-202,250
-71% -$10.7M 0.17% 116
2025
Q4
$11.3M Sell
285,506
-120,354
-30% -$4.48M 0.6% 58
2025
Q3
$15.9M Buy
+405,860
New +$12M 0.86% 37
2024
Q4
Sell
-921,451
Closed -$18.7M 132
2024
Q3
$18.7M Buy
921,451
+65,616
+8% +$1.26M 1.36% 20
2024
Q2
$19.7M Buy
855,835
+317,402
+59% +$8.03M 1.63% 15
2024
Q1
$15.7M Sell
538,433
-261,071
-33% -$5.98M 1.2% 30
2023
Q4
$15.6M Buy
+799,504
New +$14M 1.37% 18
2023
Q2
Sell
-561,894
Closed -$6.57M 121
2023
Q1
$6.57M Buy
+561,894
New +$6.5M 0.63% 56

Other funds holding ACMR

Portolan Capital Management's ACMR Position: Q2 2026 in Review

Portolan Capital Management increased its ACM Research (ACMR) stake by 113% in Q2 2026, buying an estimated $6.66M and bringing the position to 177,432 shares worth $22.5M. The position accounts for 0.84% of the portfolio, ranked #39.

Portolan Capital Management first reported a position in ACMR in Q1 2023 and has held it in 9 quarters since. 376 funds tracked by Wall St. Rank hold ACMR as of Q2 2026.

  • Portolan Capital Management held 177,432 shares of ACM Research worth $22.5M as of Q2 2026.
  • Portolan Capital Management bought 94,176 ACM Research shares in Q2 2026, an estimated $6.66M.
  • ACM Research made up 0.84% of Portolan Capital Management's portfolio in Q2 2026, its #39 holding.
  • Portolan Capital Management first reported a position in ACM Research in Q1 2023 and has held it in 9 quarters since.
  • 376 funds tracked by Wall St. Rank held ACM Research as of Q2 2026.

Based on Portolan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.